Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
50
天
Luspatercept and imetelstat for myelodysplastic syndrome: updates from ASH 2025 annual meeting
作者
Yagya Ahlawat; Heng Jiang; Delong Liu展开收起
作者单位
1. Division of Hematology and Oncology, Westchester Medical Center, New York Medical College, Valhalla, USA; 2. Department of Internal Medicine, Westchester Medical Center, New York Medical College, Valhalla, USA展开收起
75
天
Novel BTK inhibitors and degraders for relapsed/refractory CLL/SLL: latest updates from ASH 2025 annual meeting
作者
Pritika Sharma; Heng Jiang; Delong Liu展开收起
作者单位
1. Division of Hematology and Oncology, Westchester Medical Center and New York Medical College, Valhalla, USA; 2. Department of Internal Medicine, Westchester Medical Center, Valhalla, USA展开收起
94
天
Circulating tumor DNA in breast cancer: updates from SABCS 2025
作者
Iris Zhi; Xianghui Zou; Min Sun; Nancy Chan; Naomi Ko; Neil Vasan; Shridar Ganesan; Cynthia Ma展开收起
作者单位
1. Division of Hematology and Medical Oncology, NYU Langone Perlmutter Cancer Center, NYU Grossman Long Island School of Medicine, Mineola, USA; 2. Division of Hematology and Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, USA; 3. Division of Hematology and Medical Oncology, NYU Langone Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, USA; 4. Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, USA展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
